NASDAQ Approves Cardiome’s Request to Transfer its Listing to the NASDAQ Capital Market

[at noodls] – VANCOUVER, Canada, – October 25, 2012 – Cardiome Pharma Corp. (TSX: COM, Nasdaq: CRME) announced today that the NASDAQ Listing Qualifications Staff has approved the Company’s request to transfer its listing … more

View todays social media effects on CRME

View the latest stocks trending across Twitter. Click to view dashboard